Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed Apr 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$164K
Net Open-Market Flow
-$164K
Transactions
7
7 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Sell(S)284$162.76$46K13K
Apr 20, 2026Sell(S)524$163.52$86K13K
Apr 20, 2026Sell(S)124$164.40$20K13K
Apr 20, 2026Sell(S)40$165.29$7K13K
Apr 20, 2026Sell(S)3$166.91$50113K
Apr 20, 2026Sell(S)16$167.16$3K13K
Apr 20, 2026Sell(S)9$168.35$2K13K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-167281) within minutes of acceptance. Every field above traces to the original document. Verify it directly: